Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Iva337
1. 927961-18-0
2. Iva-337
3. Iva337
4. 28q8ag0pyl
5. Chembl4091374
6. Cpd1537
7. 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic Acid
8. 1h-indole-2-butanoic Acid, 1-(6-benzothiazolylsulfonyl)-5-chloro-
9. 5-chloro-1-((6-benzothiazolyl)sulfonyl)-1h-indole-2-butanoic Acid
10. 4-(1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic Acid
11. 4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1h-indol-2-yl)butanoic Acid
12. 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic Acid
13. Lanifbranor
14. Libfranor
15. Lanifbranor [inn]
16. Lanifibranor(iva-337)
17. Lanifibranor [inn]
18. Unii-28q8ag0pyl
19. Lanifibranor [who-dd]
20. Schembl3528615
21. Amy16813
22. Cmb96118
23. Ex-a1511
24. Bdbm50244350
25. S8770
26. Akos037649312
27. Db14801
28. Sb18746
29. Ac-31451
30. Bs-17993
31. Hy-104049
32. Cs-0027586
33. A903382
34. Q27896056
35. 1-(6-benzothiazolylsulfonyl)-5-chloro-1h-indole-2-butanoic Acid
36. Bjb
37. Iva-337; Iva 337;4-(1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic Acid;iva-337
| Molecular Weight | 434.9 g/mol |
|---|---|
| Molecular Formula | C19H15ClN2O4S2 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 434.0161770 g/mol |
| Monoisotopic Mass | 434.0161770 g/mol |
| Topological Polar Surface Area | 126 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 686 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
1,3-benzothiazole-6-sulfonyl chloride
CAS Number : 181124-40-3
End Use API : Lanifibranor
About The Company : LinkChem is a leading China headquartered CMO | CRO provider within the pharmaceutical industry. Our core focus includes: custom synthesis, process development,...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Lanifibranor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanifibranor, including repackagers and relabelers. The FDA regulates Lanifibranor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanifibranor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lanifibranor supplier is an individual or a company that provides Lanifibranor active pharmaceutical ingredient (API) or Lanifibranor finished formulations upon request. The Lanifibranor suppliers may include Lanifibranor API manufacturers, exporters, distributors and traders.
Lanifibranor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lanifibranor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lanifibranor GMP manufacturer or Lanifibranor GMP API supplier for your needs.
A Lanifibranor CoA (Certificate of Analysis) is a formal document that attests to Lanifibranor's compliance with Lanifibranor specifications and serves as a tool for batch-level quality control.
Lanifibranor CoA mostly includes findings from lab analyses of a specific batch. For each Lanifibranor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lanifibranor may be tested according to a variety of international standards, such as European Pharmacopoeia (Lanifibranor EP), Lanifibranor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lanifibranor USP).
LOOKING FOR A SUPPLIER?
